The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients

scientific article published on January 2017

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0961203317692437
P698PubMed publication ID28420054

P50authorEllen M GinzlerQ91640182
Susan ManziQ111603941
Kenneth C. KalunianQ111604424
Mary Anne DooleyQ111604480
Ronald van VollenhovenQ47265013
Michael MahlerQ49724482
Caroline GordonQ58049734
Diane KamenQ58664617
Marvin J FritzlerQ63302292
Graciela S AlarcónQ67485107
Michelle A. PetriQ67485110
Rosalind Ramsey-GoldmanQ67485111
Joan T MerrillQ67485131
Munther A. KhamashtaQ73418907
Sasha BernatskyQ87985660
Cynthia AranowQ91409089
Dafna D. GladmanQ37605821
Guillermo Ruiz-IrastorzaQ37830875
David A. IsenbergQ42326409
Manuel Ramos-casalsQ42646201
Christine A PeschkenQ43020820
P2093author name stringA Rahman
D J Wallace
S Jacobsen
O Nived
J G Hanly
K Steinsson
A E Clarke
P Fortin
J Sanchez-Guerrero
M B Urowitz
M Inanc
S S Lim
J Romero-Diaz
S-C Bae
A Askanase
J Buyon
M Y Choi
I N Bruce
A A Zoma
Y St Pierre
P2860cites workIsolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activationQ22008025
LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cellsQ24304259
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2Q33361237
Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseasesQ46228790
Anti-DFS70 antibodies in 597 healthy hospital workersQ47948523
DFS70 Autoantibodies are Rare in Healthy Danish Individuals but may Still Serve as a Diagnostic Aid.Q50568340
Towards a better understanding of the clinical association of anti-DFS70 autoantibodiesQ34502449
Anti-C1q antibodies in systemic lupus erythematosusQ34717540
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodiesQ35140485
Autoantibodies predate the onset of systemic lupus erythematosus in northern SwedenQ35620360
Thrombophilia Associated with Anti-DFS70 AutoantibodiesQ35784744
Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based surveyQ37080599
Epitope specificity and significance in systemic autoimmune diseasesQ37690390
The Systemic Lupus International Collaborating Clinics (SLICC) group - it was 20 years ago todayQ37957814
The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseasesQ38072928
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesQ38152619
DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and CancerQ38410970
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testingQ38674581
Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cellsQ38813885
Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescenceQ38827609
Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodiesQ39716599
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and ControlsQ40425946
Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosisQ40511437
Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohortQ43240907
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.Q43717482
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseasesQ44849932
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohortQ45345442
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectautoantibodyQ785022
P304page(s)1051-1059
P577publication date2017-01-01
P1433published inLupusQ6704846
P1476titleThe prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients
P478volume26

Reverse relations

cites work (P2860)
Q94570068Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
Q90465816Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort
Q39454840Emerging technologies in autoantibody testing for rheumatic diseases
Q55100401Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.
Q90309960Shared and unique immune alterations in pre-clinical autoimmunity
Q90003817Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions

Search more.